Roxane Laboratories, Inc. Initiates a Nationwide Recall of Two Lots of Sodium Polystyrene Sulfonate Suspension

July 16, 2008

CONTACT: JASON KURTZ 440-201-3668

FOR IMMEDIATE RELEASE — COLUMBUS, OHIO — JULY 14, 2008 — ROXANE LABORATORIES, INC. ANNOUNCED TODAY THAT IT IS CONDUCTING A NATIONWIDE VOLUNTARY RECALL OF TWO MANUFACTURING LOTS OF SODIUM POLYSTYRENE SULFONATE SUSPENSION, USP, 15 G/60 ML UNIT DOSE BOTTLES (NDC 0054-0165-51; LOT 856396A EXP APRIL 2010, AND LOT 856693A EXP MAY 2010). SODIUM POLYSTYRENE SULFONATE SUSPENSION IS USED TO TREAT HYPERKALEMIA (AN ELEVATED BLOOD LEVEL OF THE ELECTROLYTE POTASSIUM).

ROXANE LABORATORIES’ NUMBER ONE PRIORITY IS FOR THE SAFETY OF PATIENTS WHO USE OUR PRODUCTS. A SAMPLE FROM PRODUCT LOT 856396A TESTED POSITIVE FOR A STRAIN OF YEAST, WHICH COULD POTENTIALLY AFFECT IMMUNOCOMPROMISED PATIENTS. ROXANE LABORATORIES BELIEVES THAT THIS MAY BE ATTRIBUTED TO YEAST CONTAMINATION IN ONE LOT OF HIGH-DENSITY POLYETHYLENE BOTTLES RECEIVED FROM A SUPPLIER. THERE ARE VARIOUS MANIFESTATIONS OF YEAST INFECTIONS. THE RISK OF DEVELOPING A YEAST INFECTION DEPENDS ON HOW IMMUNOCOMPROMISED THE PATIENT IS. ADDITIONALLY, THERE ARE A RANGE OF SYMPTOMS IN A YEAST INFECTION FROM THRUSH, SKIN RASH, AND BLOOD INFECTIONS (SEPS

More Recalled Products at US Recall News

Written by FDA · Filed Under FDA Press Releases | Leave a Comment 

Voluntary Nationwide Recall of Rize 2 The Occasion Capsules and Rose 4 Her Capsules

July 3, 2008

CONTACT: DEVINE DISTRIBUTION: 954-418-9510 G & N WORKS: 813 549-4177 RIZE2.COM: 813 549-4177     RIZE2.INFO: 954 418-9510        

This is a preview of the article. Read the rest of Voluntary Nationwide Recall of Rize 2 The Occasion Capsules and Rose 4 Her Capsules.

Written by FDA · Filed Under FDA Press Releases | Leave a Comment 

Sage Products Inc. Recalls 2 Percent Chlorhexidine Gluconate Cloth Patient Preoperative Skin Preparation

July 1, 2008

CONTACT: KYM AFFINITO OR MIKE NYGREN 815-455-4700

FOR IMMEDIATE RELEASE — CARY, IL — JUNE 27, 2008 — AS A PRECAUTIONARY MEASURE, SAGE PRODUCTS ANNOUNCED A VOLUNTARY RECALL OF LIMITED LOTS OF 2% CHLORHEXIDINE GLUCONATE (CHG) CLOTH PATIENT PREOPERATIVE SKIN PREPARATION PRODUCT. TESTING OF BULK 2% CHG SOLUTION FROM AN OUTSIDE SUPPLIER WAS FOUND POSITIVE FOR BURKHOLDERIA CEPACIA (B. CEPACIA).

This is a preview of the article. Read the rest of Sage Products Inc. Recalls 2 Percent Chlorhexidine Gluconate Cloth Patient Preoperative Skin Preparation.

Written by FDA · Filed Under FDA Press Releases | Leave a Comment 

ETHEX Corporation Voluntarily Recalls Specific Lots of 30 mg. and 60 mg. Morphine Sulfate Extended Release Tablets

June 28, 2008

CONTACT: ANN MCBRIDE 1-800-321-1705

This is a preview of the article. Read the rest of ETHEX Corporation Voluntarily Recalls Specific Lots of 30 mg. and 60 mg. Morphine Sulfate Extended Release Tablets.

Written by FDA · Filed Under FDA Press Releases | Leave a Comment 

Abbott Announces Voluntary Worldwide Recall of Two Lots of Calcilo XD Low-Calcium/Vitamin D-Free Infant Formula with Iron Powder in 14.1-Ounce (400g) Cans (May 30)

June 4, 2008

CONTACT: CONSUMER HOTLINE (800) 638-6493

FOR IMMEDIATE RELEASE — MAY 30, 2008 — ABBOTT TODAY ANNOUNCED A VOLUNTARY WORLDWIDE RECALL OF TWO LOTS OF CALCILO XD® LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON POWDER IN 14.1-OUNCE CANS (400G). ONLY 14.1-OUNCE (400G) CANS ARE INVOLVED IN THIS ACTION. CALCILO XD® IS A LOW-CALCIUM AND VITAMIN D-FREE INFANT FORMULA THAT IS SPECIFICALLY DESIGNED FOR THE NUTRITION SUPPORT OF INFANTS AND CHILDREN WITH HYPERCALCEMIA (HIGH CALCIUM IN BLOOD). IT IS ONLY AVAILABLE BY SPECIAL ORDER.

This is a preview of the article. Read the rest of Abbott Announces Voluntary Worldwide Recall of Two Lots of Calcilo XD Low-Calcium/Vitamin D-Free Infant Formula with Iron Powder in 14.1-Ounce (400g) Cans (May 30).

Written by FDA · Filed Under FDA Press Releases | Leave a Comment 

Fresca Italia Inc Recalls Burrata For Possible Listeria Contamination

June 4, 2008

CONTACT: FRESCA ITALIA, INC. 415-468-9800

FOR IMMEDIATE RELEASE — MAY 30, 2008 — FRESCA ITALIA OF BRISBANE, CA IS RECALLING BURRATA BECAUSE IT HAS THE POTENTIAL TO BE CONTAMINATED WITH LISTERIA MONOCYTOGENES, AN ORGANISM WHICH CAN CAUSE SERIOUS INFECTIONS IN YOUNG CHILDREN, FRAIL OR ELDERLY PEOPLE, AND OTHERS WITH WEAKENED IMMUNE SYSTEMS. ALTHOUGH HEALTHY INDIVIDUALS MAY SUFFER ONLY SHORT-TERM SYMPTOMS SUCH AS FEVER, HEADACHE, STIFFNESS, NAUSEA, ABDOMINAL, OR DIARRHEA, LISTERIA INFECTION CAN CAUSE MISCARRIAGES AND STILLBIRTHS AMONG PREGNANT WOMEN.

This is a preview of the article. Read the rest of Fresca Italia Inc Recalls Burrata For Possible Listeria Contamination.

Written by FDA · Filed Under FDA Press Releases | Leave a Comment 

Viril-Ity-Power VIP Tabs Recalled

May 30, 2008

CONTACT: INTERNATIONAL PHARMACEUTICALS, LTD. ADMIN@IPLVIP.COM

FOR IMMEDIATE RELEASE — BRADFORD, MA - MAY 29, 2008 - INTERNATIONAL PHARMACEUTICALS, LTD., P.O. BOX 5165, BRADFORD, MA 01835, ANNOUNCED TODAY THAT IT IS CONDUCTING A VOLUNTARY RECALL OF ALL THE COMPANY’S SUPPLEMENT PRODUCT SOLD UNDER THE BRAND NAME OF VIRIL-ITY-POWER (VIP) TABS, 560MG/SERVING.

This is a preview of the article. Read the rest of Viril-Ity-Power VIP Tabs Recalled.

Written by FDA · Filed Under FDA Press Releases | Leave a Comment 

Digoxin Toxicity

May 29, 2008

Digoxin toxicity has always been a major problem, due to the narrow range separating medically-effective digoxin levels from toxic levels of the drug.

This is a preview of the article. Read the rest of Digoxin Toxicity.

Written by Candelaria · Filed Under Drug Recalls | Leave a Comment 

Medicis Announces Recall of Solodyn (minocycline HCL, USP) Tablets Over Product Mix-Up

May 20, 2008

CONTACT: STERICYCLE CUSTOMER SERVICE 1-888-656-6381

This is a preview of the article. Read the rest of Medicis Announces Recall of Solodyn (minocycline HCL, USP) Tablets Over Product Mix-Up.

Written by FDA · Filed Under FDA Press Releases | Leave a Comment 

Atrium Initiates Voluntary Recall Action Regarding HYDRAGLIDE Brand Heparin-Coated Thoracic Drainage Catheters

May 16, 2008

CONTACT: ATRIUM 1-800-5-ATRIUM

This is a preview of the article. Read the rest of Atrium Initiates Voluntary Recall Action Regarding HYDRAGLIDE Brand Heparin-Coated Thoracic Drainage Catheters.

Written by FDA · Filed Under FDA Press Releases | Leave a Comment 

Next Page »